Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Medtronic
Dow

Last Updated: June 30, 2022

Suppliers and packages for generic ingredient: LAMIVUDINE


✉ Email this page to a colleague

« Back to Dashboard

LAMIVUDINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Viiv Hlthcare EPIVIR lamivudine SOLUTION;ORAL 020596 NDA ViiV Healthcare Company 49702-205-48 240 mL in 1 BOTTLE (49702-205-48) 2010-10-04
Glaxosmithkline EPIVIR-HBV lamivudine SOLUTION;ORAL 021004 NDA GlaxoSmithKline LLC 0173-0663-00 240 mL in 1 BOTTLE (0173-0663-00) 1998-12-23
Aurobindo Pharma Ltd LAMIVUDINE lamivudine SOLUTION;ORAL 077695 ANDA Rising Health, LLC 57237-274-24 240 mL in 1 BOTTLE (57237-274-24) 2016-11-21
Aurobindo Pharma Ltd LAMIVUDINE lamivudine SOLUTION;ORAL 077695 ANDA Aurobindo Pharma Limited 65862-055-24 240 mL in 1 BOTTLE (65862-055-24) 2016-11-21
Lannett Co Inc LAMIVUDINE lamivudine SOLUTION;ORAL 203564 ANDA Lannett Company, Inc. 54838-566-70 240 mL in 1 BOTTLE, PLASTIC (54838-566-70) 2014-10-31
Viiv Hlthcare EPIVIR lamivudine TABLET;ORAL 020564 NDA ViiV Healthcare Company 49702-203-18 60 TABLET, FILM COATED in 1 BOTTLE (49702-203-18) 2010-10-04
Viiv Hlthcare EPIVIR lamivudine TABLET;ORAL 020564 NDA ViiV Healthcare Company 49702-204-13 30 TABLET, FILM COATED in 1 BOTTLE (49702-204-13) 2010-10-04
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Boehringer Ingelheim
Moodys
Medtronic
McKinsey